Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Antineoplastic Agents (1)
- Clinical Trials as Topic (1)
- Depsipeptides (1)
- G-Protein-Coupled (1)
- GTP-Binding Protein alpha Subunits (1)
-
- GTP-Binding Protein alpha Subunits, Gq-G11 (1)
- Genetic Predisposition to Disease (1)
- Gq-G11 (1)
- Humans (1)
- Lung cancer (1)
- Melanoma (1)
- Mutation (1)
- Neoplasm Metastasis (1)
- P53 (1)
- Poster (1)
- Poster presentation (1)
- Receptors (1)
- Receptors, G-Protein-Coupled (1)
- Signal Transduction (1)
- Tumor suppressor gene (1)
- Uveal Neoplasms (1)
- Publication
- Publication Type
Articles 1 - 2 of 2
Full-Text Articles in Medical Molecular Biology
Dysregulated Gpcr Signaling And Therapeutic Options In Uveal Melanoma., Vivian Chua, Dominic Lapadula, Clinita Randolph, Jeffrey L. Benovic, Philip B. Wedegaertner, Andrew E. Aplin
Dysregulated Gpcr Signaling And Therapeutic Options In Uveal Melanoma., Vivian Chua, Dominic Lapadula, Clinita Randolph, Jeffrey L. Benovic, Philip B. Wedegaertner, Andrew E. Aplin
Department of Biochemistry and Molecular Biology Faculty Papers
Uveal melanoma is the most common primary intraocular malignant tumor in adults and arises from the transformation of melanocytes in the uveal tract. Even after treatment of the primary tumor, up to 50% of patients succumb to metastatic disease. The liver is the predominant organ of metastasis. There is an important need to provide effective treatment options for advanced stage uveal melanoma. To provide the preclinical basis for new treatments, it is important to understand the molecular underpinnings of the disease. Recent genomic studies have shown that mutations within components of G protein-coupled receptor (GPCR) signaling are early events associated …
Urokinase Plasminogen Activator Expression Is Regulated By P53 Harboring The Lung Cancer-Specific Mutation V157f, Julie Barta, Md, Kristen Pauley, Steven B. Mcmahon, Phd
Urokinase Plasminogen Activator Expression Is Regulated By P53 Harboring The Lung Cancer-Specific Mutation V157f, Julie Barta, Md, Kristen Pauley, Steven B. Mcmahon, Phd
Department of Biochemistry and Molecular Biology Posters
OBJECTIVES
- To define the mutant p53-regulated transcriptome of lung cancer cells with alterations at V157 and R158 in the p53 tumor suppressor.
- To determine the biological effects of lung-enriched p53 mutations in lung cancer cells.